NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

I think this raise is a bridge to provide extra insurance/time to sell the remaining Sawston property for enough funds to see us through unblinding/ top line without further dilution. If unblinding/top-line were around the corner, this raise would have been un-necessary. This raise seems to be just a bridge to more substantive financing through the sale of remaining Sawston RE.

Thus, I think unblinding/top-line won't happen this year. LP may want to drag out data collection to November, 2019. In any event, the tea leaves seem to indicate that unblinding is not near-term. If that is the case, then I think the odds of the pps tanking to new lows are relatively high. If positive results are announced when the pps are at new lows, such a launch pad may not provide sufficient momentum to even reach a buck per share.

You may call this pessimistic but I rather call it realistic. Depends upon your point of view. They say that beauty is in the eye of the beholder. JMHO.